title: Anopheles gambiae PGRPLC-mediated defense against bacteria modulates infections with malaria parasites.
abstract: Recognition of peptidoglycan (PGN) is paramount for insect antibacterial defenses. In the fruit fly Drosophila melanogaster, the transmembrane PGN Recognition Protein LC (PGRP-LC) is a receptor of the Imd signaling pathway that is activated after infection with bacteria, mainly Gram-negative (Gram-). Here we demonstrate that bacterial infections of the malaria mosquito Anopheles gambiae are sensed by the orthologous PGRPLC protein which then activates a signaling pathway that involves the Rel/NF-kappaB transcription factor REL2. PGRPLC signaling leads to transcriptional induction of antimicrobial peptides at early stages of hemolymph infections with the Gram-positive (Gram+) bacterium Staphylococcus aureus, but a different signaling pathway might be used in infections with the Gram- bacterium Escherichia coli. The size of mosquito symbiotic bacteria populations and their dramatic proliferation after a bloodmeal, as well as intestinal bacterial infections, are also controlled by PGRPLC signaling. We show that this defense response modulates mosquito infection intensities with malaria parasites, both the rodent model parasite, Plasmodium berghei, and field isolates of the human parasite, Plasmodium falciparum. We propose that the tripartite interaction between mosquito microbial communities, PGRPLC-mediated antibacterial defense and infections with Plasmodium can be exploited in future interventions aiming to control malaria transmission. Molecular analysis and structural modeling provided mechanistic insights for the function of PGRPLC. Alternative splicing of PGRPLC transcripts produces three main isoforms, of which PGRPLC3 appears to have a key role in the resistance to bacteria and modulation of Plasmodium infections. Structural modeling indicates that PGRPLC3 is capable of binding monomeric PGN muropeptides but unable to initiate dimerization with other isoforms. A dual role of this isoform is hypothesized: it sequesters monomeric PGN dampening weak signals and locks other PGRPLC isoforms in binary immunostimulatory complexes further enhancing strong signals.
authors: Division of Cell and Molecular Biology, Department of Life Sciences, Imperial College London, London, UK.
authors: Stephan
authors: S
authors: Meister
authors: Bogos
authors: B
authors: Agianian
authors: Fanny
authors: F
authors: Turlure
authors: Angela
authors: A
authors: Relógio
authors: Isabelle
authors: I
authors: Morlais
authors: Fotis C
authors: FC
authors: Kafatos
authors: George K
authors: GK
authors: Christophides
mesh_terms: D017398:Alternative Splicing; D000595:Amino Acid Sequence; D000818:Animals; D000852:Anopheles / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D001424:Bacterial Infections / Q000276:immunology*; D002352:Carrier Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D004269:DNA, Bacterial / Q000235:genetics; D005260:Female; D008288:Malaria / Q000276:immunology / Q000635:transmission; D008969:Molecular Sequence Data; D010961:Plasmodium / Q000276:immunology*; D020033:Protein Isoforms / Q000276:immunology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000276:immunology
chemical_list: D002352:Carrier Proteins; D004269:DNA, Bacterial; D020033:Protein Isoforms; C118897:peptidoglycan recognition protein